IE36995L - Producing attenuated viruses. - Google Patents
Producing attenuated viruses.Info
- Publication number
- IE36995L IE36995L IE721716A IE171672A IE36995L IE 36995 L IE36995 L IE 36995L IE 721716 A IE721716 A IE 721716A IE 171672 A IE171672 A IE 171672A IE 36995 L IE36995 L IE 36995L
- Authority
- IE
- Ireland
- Prior art keywords
- virus
- attenuated
- cattle
- dec
- diluent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1356076 Attenuated virus vaccine; interferon induction BAYER AG 8 Dec 1972 [10 Dec 1971] 56723/72 Heading A5B A virus is attenuated by serial passage on tissue cultures until it will stimulate interferon production without producing specific immunity to the orginial virus. The virus may be I.P.V. virus (otherwise known as infectious pustular vulvovaginitis, Exanthema coitale vesiculosum bovis or cattle blister rash), pseudorabies virus or influenza virus. It may be passaged on calf kidney, suprarenal or testicular tissue. The attenuated virus may be compounded with a liquified gaseous diluent, isotonic fluid, a buffer solution, a liquid having a molecular weight of 200 or more or a solid diluent. The composition may be used as tablets, pills, dragees, capsules, ampoules for intramuscular injection or nasal sprays, or suppositories. They may be applied to cattle or pigs.
[GB1356076A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (en) | 1971-12-10 | 1971-12-10 | Production of virus strains which stimulate the natural defense mechanisms of a host organism without simultaneously having an antigenic effect and medicaments for the prophylaxis and treatment of viral and bacterial infections in humans and animals, containing such a virus strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE36995L true IE36995L (en) | 1973-06-10 |
| IE36995B1 IE36995B1 (en) | 1977-04-13 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1716/72A IE36995B1 (en) | 1971-12-10 | 1972-12-08 | Improvements in and relating to attenuated viruses |
Country Status (21)
| Country | Link |
|---|---|
| JP (2) | JPS6011013B2 (en) |
| AR (1) | AR204075A1 (en) |
| AT (1) | AT326817B (en) |
| AU (1) | AU473209B2 (en) |
| BE (1) | BE792484A (en) |
| BG (1) | BG21417A3 (en) |
| CA (1) | CA988848A (en) |
| CH (1) | CH577558A5 (en) |
| CS (1) | CS189587B2 (en) |
| DD (1) | DD108115A5 (en) |
| DE (1) | DE2161344C3 (en) |
| DK (1) | DK143201C (en) |
| ES (1) | ES409464A1 (en) |
| FR (1) | FR2162637B1 (en) |
| GB (1) | GB1356076A (en) |
| HU (1) | HU167086B (en) |
| IE (1) | IE36995B1 (en) |
| NL (1) | NL178014C (en) |
| PH (1) | PH12597A (en) |
| SE (1) | SE8400283L (en) |
| ZA (1) | ZA728709B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/en not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/en not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/en active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/en not_active Expired
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/en not_active Expired
- 1972-12-06 BG BG22052A patent/BG21417A3/xx unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/en not_active IP Right Cessation
- 1972-12-07 AT AT1041972A patent/AT326817B/en not_active IP Right Cessation
- 1972-12-07 CS CS728391A patent/CS189587B2/en unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 DK DK615472A patent/DK143201C/en not_active IP Right Cessation
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/en unknown
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-08 IE IE1716/72A patent/IE36995B1/en unknown
- 1972-12-09 ES ES409464A patent/ES409464A1/en not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATA1041972A (en) | 1975-03-15 |
| DE2161344B2 (en) | 1980-05-08 |
| DE2161344C3 (en) | 1986-10-02 |
| CS189587B2 (en) | 1979-04-30 |
| JPS6011013B2 (en) | 1985-03-22 |
| AT326817B (en) | 1975-12-29 |
| NL178014B (en) | 1985-08-01 |
| SE8400283D0 (en) | 1984-01-20 |
| AR204075A1 (en) | 1975-11-20 |
| BG21417A3 (en) | 1976-05-20 |
| NL7216628A (en) | 1973-06-13 |
| GB1356076A (en) | 1974-06-12 |
| ZA728709B (en) | 1973-08-29 |
| HU167086B (en) | 1975-08-28 |
| SU439956A3 (en) | 1974-08-15 |
| SE8400283L (en) | 1984-01-20 |
| JPS5924137B2 (en) | 1984-06-07 |
| FR2162637B1 (en) | 1976-07-02 |
| DK143201C (en) | 1981-12-14 |
| JPS4862912A (en) | 1973-09-01 |
| DK143201B (en) | 1981-07-20 |
| FR2162637A1 (en) | 1973-07-20 |
| AU4992072A (en) | 1974-06-13 |
| DE2161344A1 (en) | 1973-06-20 |
| AU473209B2 (en) | 1976-06-17 |
| IE36995B1 (en) | 1977-04-13 |
| PH12597A (en) | 1979-06-27 |
| CA988848A (en) | 1976-05-11 |
| JPS4862919A (en) | 1973-09-01 |
| BE792484A (en) | 1973-06-08 |
| ES409464A1 (en) | 1976-03-16 |
| NL178014C (en) | 1986-01-02 |
| DD108115A5 (en) | 1974-09-05 |
| CH577558A5 (en) | 1976-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB697619A (en) | Reducing attack by combustion products | |
| IE36995L (en) | Producing attenuated viruses. | |
| FR1512339A (en) | Process for the preparation of ceramic products having a low coefficient of expansion | |
| FR849987A (en) | Process for preparing rubber-like interpolymerization products | |
| GB899205A (en) | The purification and polymerisation of vinylene carbonate | |
| FR2275455A1 (en) | D-Hydroxyalkyl desoxyvincaminates - by hydrogenation of 2-oxoalkyl desoxyvincaminates and the corresp. apovincaminates (NO190176) | |
| FR1036376A (en) | Process for the preparation of urea formaldehyde resins resistant to attack by chemicals | |
| GB625646A (en) | Improvements in or relating to processes for manufacturing mercaptans and the products thereof | |
| TAHAMA | Studies on the dwarf disease of mulberry tree (X) Further experiments on the transmission by leafhopper, Hishimonus disciguttus Walker.-1 | |
| USD135297S (en) | Glass tumbler or similar article | |
| FR1331287A (en) | Process for purifying sodium hydroxide liquors, products purified by the present process or similar process | |
| USD201258S (en) | Page z fig | |
| USD199818S (en) | Bottle or similar article | |
| GB1396754A (en) | Process for preparing alpha-keto esters | |
| Gibson | Cathodic Protection Training Program | |
| GB1444980A (en) | Psychotropic medicinal preparation | |
| GB1330950A (en) | Synthesis of 1,2-bis-p-carboxyphenoxy ethane | |
| GB549270A (en) | A device for introducing liquid into pipettes | |
| GB1336949A (en) | Adenosine derivatives | |
| GB1007209A (en) | Improvements in or relating to the manufacture of cyclic oligomers | |
| FR1326925A (en) | Process for separating the reaction products of water, boron trifluoride and an inorganic oxide modified by this trifluoride from a liquid hydrocarbon containing these products | |
| AU413747B2 (en) | A process for concentrating and purifying influenza virus from culture media, and the preparation of a respiratory virus vaccine therefrom | |
| FR898915A (en) | Process for the preparation of condensation products of urea with aldehydes | |
| ES371341A1 (en) | 2-substituted 4-propargyloxymethyl-2-ethoxycarbonyl-gamma-butyrolactones | |
| ES248501A1 (en) | A process for the electrothermal production of magnesium |